MCL1 and neoplasm: Importantly, they extend this concept, highlighting the notion that tumor lineage may serve as a template, with MCL-1 inhibitors potentially being particularly useful for the treatment of RAF-MEK-ERK pathway-driven, neural crest-derived tumors like melanoma relative to epithelial cancers arising in the lungs, colon, and pancreas.